Attovia Therapeutics, Inc. · NASDAQ:ATTO
venBio Global Strategic Fund IV, L.P. bought 382,352 Attovia Therapeutics, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 10, 2026
On Aug 6, 2026, venBio Global Strategic Fund IV, L.P. (10% owner) bought 382,352 Attovia Therapeutics, Inc. shares at US$17.00 for US$6.5M, leaving 4,181,367 shares. Filed Aug 10, 2026 (Form 4).
- Bought
- 382,352 shares
- Price
- US$17.00
- Value
- US$6.5M
- Holding after
- 4,181,367 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Conversion | 2,311,870 | 2,311,870 | Direct | |
| Aug 6, 2026 | Common Stock | Conversion | 821,998 | 3,133,868 | Direct | |
| Aug 6, 2026 | Common Stock | Conversion | 665,147 | 3,799,015 | Direct | |
| Aug 6, 2026 | Common Stock | Buy | 382,352 | US$17.00 | 4,181,367 | Direct |
Source
Related
- Attovia Therapeutics, Inc.
- venBio Global Strategic Fund IV, L.P.
- Attovia Therapeutics, Inc. shareholders
- Form 4/A · Walsh Colin · Aug 28, 2026
- Form 4/A · Goldman Sachs Asset Management, L.P. · Aug 28, 2026
- Form 4 · Goldman Sachs & Co. LLC · Aug 13, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 12, 2026
- Schedule 13D · Frazier Life Sciences XI, L.P. · Aug 11, 2026